Van ECK Associates Corp cut its stake in shares of Nano-X Imaging Ltd. (NASDAQ:NNOX – Free Report) by 7.5% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 20,955 shares of the company’s stock after selling 1,689 shares during the period. Van ECK Associates Corp’s holdings in Nano-X Imaging were worth $151,000 as of its most recent SEC filing.
Other institutional investors also recently modified their holdings of the company. Farther Finance Advisors LLC acquired a new position in shares of Nano-X Imaging during the third quarter worth $25,000. Verition Fund Management LLC acquired a new position in shares of Nano-X Imaging during the third quarter worth $88,000. Gainplan LLC acquired a new position in shares of Nano-X Imaging during the fourth quarter worth $92,000. Kingsview Wealth Management LLC acquired a new position in shares of Nano-X Imaging during the fourth quarter worth $94,000. Finally, Creative Planning acquired a new position in shares of Nano-X Imaging during the third quarter worth $107,000. 21.49% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analyst Weigh In
NNOX has been the subject of several research analyst reports. Cantor Fitzgerald upped their price target on shares of Nano-X Imaging from $11.00 to $12.00 and gave the stock an “overweight” rating in a report on Friday, December 6th. D. Boral Capital assumed coverage on shares of Nano-X Imaging in a report on Monday, January 6th. They set a “buy” rating and a $23.00 price target for the company.
Nano-X Imaging Trading Down 1.6 %
Shares of Nano-X Imaging stock opened at $6.30 on Monday. The business has a 50-day moving average price of $7.61 and a two-hundred day moving average price of $6.79. Nano-X Imaging Ltd. has a 1-year low of $5.27 and a 1-year high of $12.65. The company has a market cap of $364.01 million, a P/E ratio of -7.41 and a beta of 1.96.
Nano-X Imaging (NASDAQ:NNOX – Get Free Report) last released its quarterly earnings data on Thursday, November 21st. The company reported ($0.23) earnings per share (EPS) for the quarter. Nano-X Imaging had a negative return on equity of 27.63% and a negative net margin of 465.38%. During the same quarter in the prior year, the firm posted ($0.37) EPS. Equities research analysts forecast that Nano-X Imaging Ltd. will post -0.92 EPS for the current fiscal year.
About Nano-X Imaging
Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode.
Recommended Stories
- Five stocks we like better than Nano-X Imaging
- How to Capture the Benefits of Dividend Increases
- Why Genuine Parts Company Is a Royally Good Buy Right Now
- What is the S&P/TSX Index?
- Industrials Are Quietly Outpacing the Market: 3 Stocks to Watch
- How to Invest in Tech StocksĀ and Top Tech Stocks to Consider
- These 5 Energy Stocks Hedge Inflation With Growth Potential
Want to see what other hedge funds are holding NNOX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nano-X Imaging Ltd. (NASDAQ:NNOX – Free Report).
Receive News & Ratings for Nano-X Imaging Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nano-X Imaging and related companies with MarketBeat.com's FREE daily email newsletter.